ArticleCureus2026
From Dyspnea to Suspected Breast Cancer: A Post-traumatic Hematoma as a Diagnostic Pitfall.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-traumatic breast hematomas are uncommon but clinically relevant, as they may closely mimic breast cancer on both clinical examination and imaging. These hematomas may be large and persistent, particularly in patients receiving anticoagulant therapy. Conversely, breast cancer itself may present with hematoma formation, creating a diagnostic pitfall. With the increasing use of cross-sectional imaging for non-breast indications, incidental breast findings are detected with growing frequency. Although many of these findings are benign, their imaging appearance can occasionally mimic malignancy, often necessitating further diagnostic evaluation. We report the case of a 76-year-old woman who presented with progressive dyspnea, leading to a chest computed tomography (CT) for pulmonary evaluation. This examination revealed an incidental breast mass-like lesion. The patient reported a recent fall with subsequent ecchymosis of both breasts while on chronic anticoagulant therapy with apixaban. Clinical examination six months after the fall still demonstrated a large palpable mass measuring 60 x 50 mm with associated skin retraction in the right breast. The lesions in the left breast had resolved completely. Mammography, ultrasound, and magnetic resonance imaging (MRI) resulted in a Breast Imaging Reporting and Data System (BI-RADS) IV classification. The clinical examination in combination with the breast imaging was suggestive of locally advanced breast cancer. A core biopsy showed benign findings consistent with an organizing hematoma. It could, however, not rule out a malignant lesion. Following a multidisciplinary team meeting discussion, it was decided to repeat the clinical examination, imaging, and biopsy after two months. After two months, the deformation of the breast had increased, and the image was still BI-RADS IV, but the repeated core biopsy confirmed a complex organized hematoma without evidence of carcinoma. This case illustrates the diagnostic challenges associated with post-traumatic breast lesions. In this patient, clinical examination and imaging were unable to reliably distinguish an organized hematoma from breast cancer despite a clear history of trauma and anticoagulant therapy. Histological confirmation was therefore required. Persistent clinical-radiological discordance required a multidisciplinary approach. The decision to repeat the assessment after an appropriate follow-up was essential to ensure diagnostic safety and avoid both delayed cancer diagnosis and unnecessary overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.